No Data
No Data
Psychedelics-Focused Numinus Plans To Leverage This AI Technology Via New Strategic Acquisition
Psychedelics-focused mental healthcare company Numinus Wellness Inc. (TSX:NUMI) (OTCQX:NUMIF) (FSE: LR23) plans to take over MedBright AI Investments Inc. (CSE:MBA).The proposed transaction comes as t
MedBright AI Announces Strategic Acquisition by Numinus Wellness
Plans name change to "Numinus Intelligence" leveraging its current revenue generating operations to AI-enable mental health clinics across the US The strategic combination merges MedBright's AI-enabled clinical solution
Numinus Clarifies Disclosures
Psychedelic Stocks Fall as FDA Panel Rejects MDMA Therapy
Psychedelic Stocks Mixed as FDA Comments on MDMA Therapy
Numinus and Cybin Embark on a Groundbreaking Journey: Pioneering Phase 3 Trials for Major Depressive Disorder
No Data